These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 148746)

  • 1. [Anticholinergic block of allergic bronchospasm in bronchial asthma].
    Abrosimov VN; Brukmaĭerova MR
    Ter Arkh; 1978; 50(3):22-6. PubMed ID: 148746
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparative study of the bronchodilating action of fenoterol and ipratropium bromide administered by aerosols in acute attacks of asthma].
    Della Toffola A; Ardizzi A; Giorgis GE; Galietti F; Massaglia GM; Onoscuri E
    Minerva Med; 1986 May; 77(22-23):1005-8. PubMed ID: 2941697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Possibilities of reducing the doses of beta-adrenergic bronchodilators (Berotec) in combination with an anticholinergic drug (Atrovent) in bronchial asthma].
    Anastasatu C; Dutu St; Morgenstern H
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1983; 32(3):257-60. PubMed ID: 6318297
    [No Abstract]   [Full Text] [Related]  

  • 4. [Fenoterol, ipratropium bromide and their combination in the therapy of bronchospasm].
    Petraglia A; Cecere L; Scarpitta M; Funaro G; Siano V
    Clin Ter; 1983 Mar; 104(5):395-401. PubMed ID: 6221858
    [No Abstract]   [Full Text] [Related]  

  • 5. Protective and bronchospasmolytic effect of ipratropium bromide in bronchial antigen challenge tests compared to other antiasthmatic drugs.
    Gonsior E; Schultze-Werninghaus G
    Scand J Respir Dis Suppl; 1979; 103():219-21. PubMed ID: 155302
    [No Abstract]   [Full Text] [Related]  

  • 6. [The use of Atrovent for the prevention prophylaxis of the bronchospasm (author's transl)].
    Papathéodossiou N
    Schweiz Rundsch Med Prax; 1979 Jun; 68(23):740-2. PubMed ID: 156357
    [No Abstract]   [Full Text] [Related]  

  • 7. [Evaluation of the therapeutic effect of bronchodilator drugs administered as aerosols].
    Giuliano V; Martelli GC; Azzara' C
    Arch Monaldi; 1980; 35(4):175-84. PubMed ID: 6211154
    [No Abstract]   [Full Text] [Related]  

  • 8. [Comparison by double-blind study of the combination of an aerosol of salbutamol and ipratropium bromide and its individual effect in chronic bronchitis and bronchial asthma].
    Baños Hidalgo P; Ramos Martos A; Cabrera Moreno R; Luque Leal J; Palacios Giner A
    Rev Clin Esp; 1983 Nov; 171(4):265-8. PubMed ID: 6229844
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of an adrenergic-parasympatholytic aerosol combination on the respiratory function].
    Rossi A; Rampulla C; Nascimbene T; Casali L
    Minerva Med; 1979 Jan; 70(4):333-46. PubMed ID: 155228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new parasympatholytic bronchodilator: a study of its onset of effect after inhalation.
    Emirgil C; Dwyer K; Baskette P; Sobol BJ
    Curr Ther Res Clin Exp; 1975 Mar; 17(3):215-24. PubMed ID: 805016
    [No Abstract]   [Full Text] [Related]  

  • 11. Ipratropium bromide (Sch 1000) monohydrate aerosol: bronchodilator effect of three dose levels in asthmatics.
    Ruffin RE; Newhouse MT
    Lung; 1978; 155(2):141-6. PubMed ID: 149884
    [No Abstract]   [Full Text] [Related]  

  • 12. The labelling and monitoring of lung deposition of an inhaled synthetic anticholinergic bronchodilating agent.
    Short MD; Singh CA; Few JD; Studdy PR; Heaf PJ; Spiro SG
    Chest; 1981 Dec; 80(6 Suppl):918-21. PubMed ID: 6458460
    [No Abstract]   [Full Text] [Related]  

  • 13. [Role of bronchospasm in impairment of bronchial permeability in bronchial asthma in attack-free period].
    Nefedov VB; Popova LA
    Klin Med (Mosk); 1999; 77(12):30-3. PubMed ID: 10684212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of metaproterenol and isoproterenol aerosols: spirometric evaluation after two months' therapy.
    Chervinsky P; Belinkoff S
    Ann Allergy; 1969 Dec; 27(12):611-6. PubMed ID: 5387334
    [No Abstract]   [Full Text] [Related]  

  • 15. [Die therapeutischen Grundlagen des exogen-allergisch ausgelösten Bronchospasmus].
    Kummer F
    Wien Klin Wochenschr; 1976 Oct; 88(20):669-74. PubMed ID: 136812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review of ipratropium bromide in induced bronchospasm in patients with asthma.
    Morris HG
    Am J Med; 1986 Nov; 81(5A):36-44. PubMed ID: 2947459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of conventional and ultrasonic nebulisation of bronchodilator drugs in asthmatic subjects.
    Sears MR
    N Z Med J; 1983 Nov; 96(743 Pt 2):927-9. PubMed ID: 6226884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single dose comparison of salbutamol and a fenoterol/ipratropium combination from metered aerosols in patients with asthma.
    Crane J; Gamble S
    N Z Med J; 1986 Jun; 99(803):420-1. PubMed ID: 2942806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anticholinergic agents as bronchodilator agents. Significance of acetylcholine as a bronchoconstrictor transmitter agent in airway obstruction].
    Ulmer WT; Dorsch J; Iravani J; Schüler KG; Stempel G; Vastag E
    Arzneimittelforschung; 1973 Mar; 23(3):468-76. PubMed ID: 4740138
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pharmacological protection against bronchospasm in bronchial asthma].
    Vondra V; Růzicka J; Spicák V
    Vnitr Lek; 1978 Nov; 24(11):1107-11. PubMed ID: 152507
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.